IN2014DN09830A - - Google Patents

Download PDF

Info

Publication number
IN2014DN09830A
IN2014DN09830A IN9830DEN2014A IN2014DN09830A IN 2014DN09830 A IN2014DN09830 A IN 2014DN09830A IN 9830DEN2014 A IN9830DEN2014 A IN 9830DEN2014A IN 2014DN09830 A IN2014DN09830 A IN 2014DN09830A
Authority
IN
India
Prior art keywords
formula
vivo
exhibits
correction
enabling
Prior art date
Application number
Other languages
English (en)
Inventor
Chenfeng Ke
Anthony P Davis
Original Assignee
Univ Bristol
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Bristol filed Critical Univ Bristol
Publication of IN2014DN09830A publication Critical patent/IN2014DN09830A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/0004Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D257/00Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/10Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/145Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/14532Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/145Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/1455Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/52Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/66Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood sugars, e.g. galactose
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/04Endocrine or metabolic disorders
    • G01N2800/042Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Optics & Photonics (AREA)
  • Surgery (AREA)
  • Medical Informatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Emergency Medicine (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IN9830DEN2014 2012-04-27 2013-04-26 IN2014DN09830A (enrdf_load_stackoverflow)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1207392.0A GB201207392D0 (en) 2012-04-27 2012-04-27 Novel compounds
PCT/GB2013/051079 WO2013160701A1 (en) 2012-04-27 2013-04-26 Anthracenyl - tetralactam macrocycles and their use in detecting a target saccharide

Publications (1)

Publication Number Publication Date
IN2014DN09830A true IN2014DN09830A (enrdf_load_stackoverflow) 2015-08-07

Family

ID=46330449

Family Applications (1)

Application Number Title Priority Date Filing Date
IN9830DEN2014 IN2014DN09830A (enrdf_load_stackoverflow) 2012-04-27 2013-04-26

Country Status (9)

Country Link
US (2) US9610365B2 (enrdf_load_stackoverflow)
EP (1) EP2855439B1 (enrdf_load_stackoverflow)
CN (1) CN104428290B (enrdf_load_stackoverflow)
AU (1) AU2013254450A1 (enrdf_load_stackoverflow)
CA (1) CA2910581A1 (enrdf_load_stackoverflow)
GB (2) GB201207392D0 (enrdf_load_stackoverflow)
HK (1) HK1209112A1 (enrdf_load_stackoverflow)
IN (1) IN2014DN09830A (enrdf_load_stackoverflow)
WO (1) WO2013160701A1 (enrdf_load_stackoverflow)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201207392D0 (en) 2012-04-27 2012-06-13 Univ Bristol Novel compounds
JP7427449B2 (ja) * 2017-03-15 2024-02-05 ノヴォ・ノルディスク・リサーチ・センター・オックスフォード・リミテッド 大員環化合物
JP7439062B2 (ja) * 2018-09-19 2024-02-27 ノヴォ・ノルディスク・リサーチ・センター・オックスフォード・リミテッド グルコース感受性インスリンおよびその使用
US11410752B2 (en) 2019-07-30 2022-08-09 Emd Millipore Corporation Method of synthesizing chemical compounds
RU2752711C2 (ru) * 2019-11-18 2021-07-30 Общество с ограниченной ответственностью «Лаборатория межклеточных технологий «Интерсел Рэнд» (ООО «Интерсел Рэнд») Способ и устройство для спектроскопии живой ткани
KR20230127067A (ko) * 2022-02-24 2023-08-31 삼성에스디아이 주식회사 코어-쉘 염료, 이를 포함하는 근적외선 흡수성 수지 조성물 및 근적외선 흡수 필름

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6815901A (en) * 2000-06-02 2001-12-17 Zycos Inc Delivery systems for bioactive agents
JP2003073399A (ja) * 2001-08-31 2003-03-12 Japan Science & Technology Corp 発蛍光性修飾タンパク質
US7179616B1 (en) 2002-10-07 2007-02-20 University Of Notre Dame Du Lac Method for detecting phosphatidylserine on the surface of cells
US8642014B2 (en) * 2007-01-30 2014-02-04 Seta Biomedicals, Llc Luminescent compounds
WO2011059457A1 (en) 2009-11-16 2011-05-19 University Of Notre Dame Du Lac High performance luminescent compounds
WO2011087521A1 (en) * 2010-01-13 2011-07-21 University Of Notre Dame Du Lac Chemiluminescent dyes and dye-stained particles
GB201207392D0 (en) 2012-04-27 2012-06-13 Univ Bristol Novel compounds

Also Published As

Publication number Publication date
CN104428290B (zh) 2017-11-14
AU2013254450A1 (en) 2014-11-27
US20170266321A1 (en) 2017-09-21
EP2855439B1 (en) 2017-06-14
CN104428290A (zh) 2015-03-18
US9937272B2 (en) 2018-04-10
EP2855439A1 (en) 2015-04-08
GB201420937D0 (en) 2015-01-07
WO2013160701A1 (en) 2013-10-31
GB2517345A (en) 2015-02-18
HK1209112A1 (en) 2016-03-24
US20150147275A1 (en) 2015-05-28
US9610365B2 (en) 2017-04-04
CA2910581A1 (en) 2013-10-31
GB201207392D0 (en) 2012-06-13

Similar Documents

Publication Publication Date Title
EA201591064A1 (ru) Новые производные пиридина
MY156938A (en) Hexafluoroisopropyl carbamate derivatives, their preparation and their therapeutic application
WO2014062720A3 (en) Methods of treating cancer
PH12014502169A1 (en) N-cyclylamides as nematicides
IN2014DN09830A (enrdf_load_stackoverflow)
EA201591527A1 (ru) Новые производные пиридина
HK1199100A1 (en) Methods and compositions for the treatment and diagnosis of colorectal cancer
WO2013089882A3 (en) Recurrent gene fusions in breast cancer
WO2012158780A3 (en) Lung cancer signature
WO2015077635A8 (en) Macromolecular antioxidants based on dual type moiety per molecule: structures methods of making and using the same
WO2011009539A8 (de) ε-POLYLYSIN-KONJUGATE UND DEREN VERWENDUNG
WO2014086982A3 (en) Stable metal compounds, their compositions and methods of their use
GEP20156318B (en) Heteroaryl derivatives as alpha7 nachr modulators
MX388850B (es) Derivados de heteroarilpiperidina y de heteroarilpiperazina como fungicidas.
NZ597570A (en) N1-acyl-5-fluoropyrimidinone derivatives
WO2013103301A3 (en) Method for preparing cell targeting conjugates, and the complexes obtained
NI201100149A (es) Derivados de tiadiazoles y oxadiazoles, su preparación y su aplicación en terapia.
EA201070009A1 (ru) Производные 7-алкинил-1,8-нафтиридонов, их получение и их применение в терапии
MX349373B (es) Nuevos derivados de pirazina.
MX342947B (es) Tratamiento de diabetes tipo 2.
WO2014039533A3 (en) Preventing pulmonary recurrence of cancer with lipid-complexed cisplatin
HK1214128A1 (zh) 癌症的治療
MX2012010127A (es) Derivados de aminoindanos, su preparacion y su aplicacion en terapeuticos.
TR201903918T4 (tr) Bir dağıtım ajanı içeren bileşimler ve bunların hazırlanması.
MX356126B (es) Uso de estabilizadores de glutamina.